SEC Comment Letter for AETHLON MEDICAL INC (AEMD) (CIK 0000882291) (AEMD) — Mar 26, 2020
AETHLON MEDICAL INC (AEMD) (CIK 0000882291)
Date: March 26, 2020 · CIK: 0000882291 · Accession: 0000000000-20-002645
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-237269
Letter
March 26, 2020 James B. Frakes Chief Financial Officer Aethlon Medical, Inc. 9635 Granite Ridge Drive, Suite 100 San Diego, California 92123 Re:Aethlon Medical, Inc. Registration Statement on Form S-3 Filed March 19, 2020 File No. 333-237269 Dear Mr. Frakes: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Irene Paik at 202-551-6553 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Julie M. Robinson, Cooley LLP
Show Raw Text
March 26, 2020
James B. Frakes
Chief Financial Officer
Aethlon Medical, Inc.
9635 Granite Ridge Drive, Suite 100
San Diego, California 92123
Re:Aethlon Medical, Inc.
Registration Statement on Form S-3
Filed March 19, 2020
File No. 333-237269
Dear Mr. Frakes:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Irene Paik at 202-551-6553 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Julie M. Robinson, Cooley LLP